We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$35.2B
AUM Growth
+$2.25B
Cap. Flow
+$1.59B
Cap. Flow %
4.52%
Top 10 Hldgs %
5.35%
Holding
3,470
New
295
Increased
1,678
Reduced
1,270
Closed
203

Sector Composition

Rank Sector Weight
1 Financials 11.12%
2 Technology 11.03%
3 Industrials 10.67%
4 Consumer Discretionary 9.98%
5 Healthcare 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COA
2926
DELISTED
COASTAL CONTACTS INC COMMON SHARES (CANADA)
COA
$169K ﹤0.01%
+15,000
New +$139K
CERS icon
2927
Cerus
CERS
$474M
$168K ﹤0.01%
35,020
+5,511
+19% +$35.4K
SPAB icon
2928
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.77B
$168K ﹤0.01%
6,250
FBNK
2929
DELISTED
First Connecticut Bancorp, Inc
FBNK
$168K ﹤0.01%
+10,728
New +$169K
MNR
2930
DELISTED
Monmouth Real Estate Investment Corp
MNR
$165K ﹤0.01%
+17,302
New +$162K
AGRO icon
2931
Adecoagro
AGRO
$1.36B
$163K ﹤0.01%
20,000
-14,311
-42% -$112K
RBBN icon
2932
Ribbon Communications
RBBN
$383M
$163K ﹤0.01%
9,667
+5,604
+138% +$93.2K
ENVE
2933
DELISTED
ENVENTIS CORP COM STK
ENVE
$163K ﹤0.01%
12,755
+1,993
+19% +$27.1K
CBB
2934
DELISTED
Cincinnati Bell Inc.
CBB
$162K ﹤0.01%
9,407
+3,271
+53% +$57.7K
GFA
2935
DELISTED
Gafisa S.A.
GFA
$162K ﹤0.01%
3,779
-479
-11% -$18K
GALT icon
2936
Galectin Therapeutics
GALT
$227M
$161K ﹤0.01%
+10,523
New +$150K
PALI icon
2937
Palisade Bio
PALI
$367M
0
RSO
2938
DELISTED
Resource Capital Corp.
RSO
$160K ﹤0.01%
7,179
+4,461
+164% +$105K
FDI
2939
DELISTED
FORT DEARBORN INCOME SECS
FDI
$160K ﹤0.01%
+11,111
New +$159K
BDSI
2940
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$159K ﹤0.01%
18,804
+3,061
+19% +$24.7K
PLXT
2941
DELISTED
PLX TECHNOLOGY INC
PLXT
$158K ﹤0.01%
26,203
+4,311
+20% +$26.5K
DTLK
2942
DELISTED
Datalink Corp
DTLK
$157K ﹤0.01%
+11,265
New +$154K
TWGP
2943
DELISTED
TOWER GROUP INTL LTD COM STK (BERMUDA)
TWGP
$157K ﹤0.01%
+58,287
New +$158K
AMPE
2944
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$156K ﹤0.01%
82
+21
+34% +$49.7K
VIRX
2945
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$155K ﹤0.01%
111
+27
+32% +$31.4K
XLP icon
2946
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$154K ﹤0.01%
3,585
-70
-2% -$2.94K
CMK
2947
DELISTED
MFS HIGH INCOME MUNI TR I
CMK
$150K ﹤0.01%
18,021
-1,830
-9% -$15.1K
IMMR icon
2948
Immersion
IMMR
$252M
$149K ﹤0.01%
14,109
+2,200
+18% +$24.7K
DSCI
2949
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$149K ﹤0.01%
+11,823
New +$153K
NATR icon
2950
Nature's Sunshine
NATR
$288M
$148K ﹤0.01%
+10,707
New +$169K

Similar funds

Guggenheim Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Guggenheim Capital held 3,470 positions worth $35.2B, up 6.8% from $32.9B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Guggenheim Capital deployed $1.59B of net new capital in Q1 2014, opening 295 new positions and adding to 1,678 existing holdings. Its largest new stake was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,154,388 shares worth $23.9M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 12% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $39M trimmed.

  • Guggenheim Capital's largest Q1 2014 buy was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,154,388 shares worth $23.9M.
  • Guggenheim Capital added most to State Street SPDR S&P 500 ETF Trust in Q1 2014, an estimated $86.8M increase.
  • Guggenheim Capital's biggest Q1 2014 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $39M.
  • Guggenheim Capital fully exited GUGGENGEIM BULLETSHARES 2014 HIGH YIELD CORPORATE BOND ETF in Q1 2014, selling an estimated $65.1M.
  • Guggenheim Capital's ten largest holdings make up 5.3% of its $35.2B portfolio in Q1 2014.
  • Guggenheim Capital opened 295 new positions and closed 203 in Q1 2014.
  • Guggenheim Capital's portfolio value rose 6.8% quarter-over-quarter to $35.2B.

Based on Guggenheim Capital's 13F filing for Q1 2014, filed 16 May 2014.